# Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis

> **NCT04368039** · NA · RECRUITING · sponsor: **Nicholas Breitborde** · enrollment: 20 (estimated)

## Conditions studied

- Psychosis
- Schizophrenia
- First-episode Psychosis

## Interventions

- **DEVICE:** Normobaric Oxygen
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT04368039
- **Lead sponsor:** Nicholas Breitborde
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-12-04
- **Primary completion:** 2026-12-07
- **Final completion:** 2026-12-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04368039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04368039, "Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT04368039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*